Alyeska Investment Group Portfolio holdings
AUM
$28.2B
1-Year Return
38.86%
This Quarter Return
+7.96%
1 Year Return
+38.86%
3 Year Return
+101.95%
5 Year Return
+160.93%
10 Year Return
+424.53%
AUM
$13.2B
AUM Growth
+$1.83B
(+16%)
Cap. Flow
+$1.15B
Cap. Flow
% of AUM
8.71%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
632
New
173
Increased
127
Reduced
126
Closed
127
Top Buys
| 1 |
NVIDIA
NVDA
|
$260M |
| 2 |
ATVI
Activision Blizzard Inc.
ATVI
|
$189M |
| 3 |
Microsoft
MSFT
|
$163M |
| 4 |
Ulta Beauty
ULTA
|
$141M |
| 5 |
Boeing
BA
|
$130M |
Top Sells
| 1 |
Adobe
ADBE
|
$387M |
| 2 |
Meta Platforms (Facebook)
META
|
$125M |
| 3 |
Walt Disney
DIS
|
$120M |
| 4 |
Texas Instruments
TXN
|
$117M |
| 5 |
AbbVie
ABBV
|
$117M |
Sector Composition
| 1 | Technology | 22.81% |
| 2 | Healthcare | 15.48% |
| 3 | Industrials | 15.2% |
| 4 | Consumer Discretionary | 14.12% |
| 5 | Energy | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Metals Acquisition
MTAL
$1B
| $937K | 0.01% |
+90,928
| New | +$937K |
|
427
Karyopharm Therapeutics
KPTI
$57.2M
| $862K | 0.01% |
32,113
| – | – |
|
428
Cytek Biosciences
CTKB
$511M
| $854K | 0.01% |
100,000
| – | – |
|
429
Quanta Services
PWR
$55.5B
| $844K | 0.01% |
+4,297
| New | +$844K |
|
430
AN2 Therapeutics
ANTX
$34.4M
| $837K | 0.01% |
98,426
+50,000
| +103% | +$425K |
|
431
CommScope
COMM
$3.55B
| $831K | 0.01% |
+147,562
| New | +$831K |
|
432
Hyperfine
HYPR
$91.9M
| $806K | 0.01% |
375,000
-375,000
| -50% | -$806K |
|
|
AMPS
433
DELISTED
Altus Power, Inc.
AMPS
| $792K | 0.01% |
146,741
| – | – |
|
434
Talkspace
TALK
$437M
| $776K | 0.01% |
611,384
-536,437
| -47% | -$681K |
|
435
MaxCyte
MXCT
$150M
| $765K | 0.01% |
+166,630
| New | +$765K |
|
436
Artesian Resources
ARTNA
$343M
| $754K | 0.01% |
+15,973
| New | +$754K |
|
437
Domino's
DPZ
$15.7B
| $748K | 0.01% |
+2,221
| New | +$748K |
|
|
AKLI
438
DELISTED
Akili, Inc. Common Stock
AKLI
| $746K | 0.01% |
672,500
| – | – |
|
439
Goldman Sachs
GS
$223B
| $742K | 0.01% |
2,301
-21,351
| -90% | -$6.89M |
|
440
Visa
V
$666B
| $722K | 0.01% |
3,039
-81,052
| -96% | -$19.2M |
|
441
Ford
F
$46.7B
| $707K | 0.01% |
+46,698
| New | +$707K |
|
442
Fulcrum Therapeutics
FULC
$414M
| $667K | 0.01% |
202,148
+50,000
| +33% | +$165K |
|
443
Mineralys Therapeutics
MLYS
$2.7B
| $639K | ﹤0.01% |
37,500
| – | – |
|
444
T Rowe Price
TROW
$23.8B
| $639K | ﹤0.01% |
+5,704
| New | +$639K |
|
|
DEN
445
DELISTED
Denbury Inc.
DEN
| $605K | ﹤0.01% |
+7,009
| New | +$605K |
|
446
Cogent Biosciences
COGT
$1.82B
| $592K | ﹤0.01% |
+50,000
| New | +$592K |
|
447
GeneDx Holdings
WGS
$3.81B
| $587K | ﹤0.01% |
98,553
+1
| +0% | +$6 |
|
448
Elutia
ELUT
$79.7M
| $506K | ﹤0.01% |
214,343
| – | – |
|
449
American Well
AMWL
$113M
| $498K | ﹤0.01% |
11,856
| – | – |
|
450
SES AI
SES
$395M
| $488K | ﹤0.01% |
200,000
+169,045
| +546% | +$412K |
|